NCT07083687 2025-07-24Lorlatinib in ROS1+ NSCLC With Brain MetastasisHunan Cancer HospitalPhase 2 Not yet recruiting21 enrolled
NCT06690541 2024-11-15COMLORLAPeking University Cancer Hospital & InstituteNot yet recruiting100 enrolled
NCT06282874 2024-02-28Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal MetastasesGuangdong Association of Clinical TrialsPhase 4 Not yet recruiting50 enrolled